Latest News

(UroToday.com) Despite wide-spread adoption, there is a paucity of data on oncologic outcomes after robot-assisted partial nephrectomy and no predictive models. At the American Urological Association (AUA) 2020 Virtual Meeting, Alessandro Larcher, MD, and colleagues presented results of their study investigating predictors of adverse oncologic outcomes in renal cell carcinoma (RCC) patients treated with robot-assisted partial […]

(UroToday.com) Blue light cystoscopy has been shown to not only increase the detection rate of non-muscle invasive bladder cancer (20% for any tumor) including carcinoma in situ (CIS; 25-43%), it also decreases recurrence (27% at 12 months) and progression rates (24% at 24 months). Flexible blue light cystoscopy was approved by the U.S. Food and […]

(UroToday.com) In this session discussing what the urologist needs to know about genetic testing, several topics were presented. These included: Basic concepts in genetic testing for prostate cancer Implementation of germline testing for prostate cancer data from the Philadelphia prostate cancer consensus conference in 2019 Genetic testing in the urology clinic Take home message for the […]

(UroToday.com) There are multiple ongoing salvage intravesical therapy trials for patients with non-muscle invasive bladder cancer who do not respond to Bacillus Calmette-Guérin (BCG). However, oncologic outcomes for patients who fail salvage intravesical therapy are not well established. At the American Urological Association (AUA) 2020 Virtual Meeting, Vignesh Packiam, MD, and colleagues presented results of their […]

(UroToday.com) Ischemia time during partial nephrectomy is one of the greatest determinants of acute kidney injury. But whether this association is affected by the preoperative risk of acute kidney injury has never been investigated. At the 2020 American Urological Association (AUA) Virtual Meeting, Carlo Andrea Bravi, MD, and colleagues presented results of their study assessing […]

(UroToday.com) The John K. Lattimer Lecture at the 2020 American Urologic Association (AUA) Virtual Annual Meeting was provided by J. Curtis Nickel, MD, discussing the impact of the urinary microbiome on urologic disease. Dr. Nickel notes that the traditional dogma is that the urinary tract is normally sterile, a belief that has persisted until the last […]

(UroToday.com) It is known that obesity is extremely common in the United States and affects approximately 60 million people. This number is expected to rise to an alarming 50% of the population in 2030 (Figure 1). High body-mass index (BMI) can affect quality metrics like readmission to hospitals. In this presented study, the authors used […]

(UroToday.com) The diagnostic process may be extensive in patients with non-muscle invasive bladder cancer (NMIBC) who have positive or suspicious urinary cytology when white-light flexible cystoscopy is negative. The next step in management is typically to proceed with resection biopsies and exclusion of upper urinary tract tumors, procedures that are performed in the operating room, which […]

(UroToday.com) The uptake of a rapid and streamlined diagnostic approach for suspected prostate cancer is growing. The use of pre-biopsy multiparametric MRI in a patient with suspected prostate cancer can lead to additional time in the diagnostic pathway and regional variation. In this study, the authors report the updated outcomes from the one-stop rapid access […]

(UroToday.com) It is known that men with testicular germ cell tumors are at an increased risk of developing a metachronous contralateral testicular germ cell tumor. Data on this risk from large population-based studies are scarce. It is currently unclear whether treatment with chemotherapy leads to a lower risk of a contralateral testicular germ cell tumor […]